Dermatitis, Pharmaceutical and Therapy - Esthetician Leadership Today

Oh, The Places Dermatology Will Go in 2024!

The Dermatology Digest

FEBRUARY 8, 2024

This will be a game-changer if it pans out and may get us closer to disease cures via optimization of existing biological therapies,” he says. Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., Hands Up for New CHE therapies Chronic hand eczema (CHE) will also get some love in 2024. And the Skin Disease of the Year Is….

Dermatology

Dermatology Eczema Pharmaceutical Dermatitis

There’s Something About Eblasakimab: Aslan, Zenyaku Partner to Investigate How it Differs From Other Biologics for AD

The Dermatology Digest

MAY 2, 2024

Aslan and Zenyaku are teaming up to explore how eblasakimab’s mechanism of action differs from that of other biologic therapies for atopic dermatitis (AD).

Pharmaceutical

Pharmaceutical Dermatitis Office Clinic

Off-label Pearl: Exploring the Role of Narrowband UVB Phototherapy Plus Oral JAK Inhibitors in Vitiligo

The Dermatology Digest

MARCH 11, 2024

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatitis

Dermatitis Eczema Dermatology Pharmaceutical

Case 2: Female, 15 Years Old

Dermatology Times

DECEMBER 19, 2023

Dr Bhutani presents the case of a 15-year-old female with long standing atopic dermatitis and discusses the importance of balancing parental preferences for "natural" agents with effective pharmaceutical options.

Pharmaceutical

Pharmaceutical Dermatitis Therapy

Breaking News: Japan First in the World to Approve Dupilumab for CSU

The Dermatology Digest

FEBRUARY 16, 2024

The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy.

Pharmaceutical

Pharmaceutical Safety Therapy Dermatitis

LEVEL UP Period 2 Data: AD Patients Who Switched From Dupilumab to Upadacitinib Hit Higher Treatment Targets

The Dermatology Digest

OCTOBER 26, 2024

Atopic dermatitis (AD) patients who switched to upadacitinib (Rinvoq, AbbVie) from dupilumab (Dupixent, Regeneron, and Sanofi) hit higher treatment targets, according to results from Period 2 of the LEVEL UP study. The most frequently reported TEAEs included nasopharyngitis, acne, upper respiratory tract infection, and atopic dermatitis.

Treatments

Treatments Dermatitis Pharmaceutical Eczema

Sneak Peek Inside the CSU Treatment Pipeline

The Dermatology Digest

MARCH 10, 2024

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Treatments

Treatments Pharmaceutical Dermatitis Eczema

Think Twice: Is It Really AD?

The Dermatology Digest

MARCH 11, 2024

Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis

Dermatitis Eczema Dermatology Pharmaceutical

Isotretinoin: Current Thinking and Best Practices

The Dermatology Digest

MARCH 11, 2024

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatitis

Dermatitis Eczema Dermatology Pharmaceutical

Rational Combinations in Acne

The Dermatology Digest

MARCH 11, 2024

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatitis

Dermatitis Eczema Dermatology Pharmaceutical

Late-breaking Data: Congenital Ichthyosis Treatment Update

The Dermatology Digest

MARCH 10, 2024

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Topical isotretinoin, even when covering 90% of a patient’s body surface area, showed minimal systemic absorption. Watch Now The Lowdown on Molluscum Nanette B. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Treatments

Treatments Dermatitis Eczema Dermatology

10 Key Causes of Dry, Itchy Scalp and How to Manage Them Effectively

First Derm

DECEMBER 26, 2023

Dandruff (Seborrheic Dermatitis) Dandruff, medically known as seborrheic dermatitis , is a common scalp condition marked by excessive shedding of skin cells. Skin Conditions (Eczema, Psoriasis, Contact Dermatitis) as Causes of Dry, Itchy Scalp Various skin conditions can lead to a dry, itchy scalp: a.

Management

Management Dermatitis Eczema Consultations

Exploring Emerging Treatments for CSU

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).

Treatments

Treatments Dermatitis Dermatology Eczema

Pro Pearls for Diagnosing Genodermatoses

The Dermatology Digest

MARCH 13, 2024

Genodermatoses can masquerade as atopic dermatitis (AD). Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Think Twice: Is It Really AD?

Dermatitis

Dermatitis Dermatology Clinic Eczema

Oh, What a Year: TDD Looks Back at 2023 in Dermatology

The Dermatology Digest

DECEMBER 15, 2023

AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. He hopes that 2024 ushers in the “virtuous cycle of therapy” for AD patients. “Now we have a delivery system for what was experimental and off-label.”

Dermatology

Dermatology Pharmaceutical Clinic Therapy

Oh, What a Year: TDD Looks Back at 2023 in Dermatology

The Dermatology Digest

DECEMBER 15, 2023

AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. He hopes that 2024 ushers in the “virtuous cycle of therapy” for AD patients. “Now we have a delivery system for what was experimental and off-label.”

Dermatology

Dermatology Pharmaceutical Clinic Therapy

Complementary Approaches to Treating Skin and Systemic Malignancy in Cancer Patients

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD).

Dermatitis

Dermatitis Dermatology Clinic Skin Issues

Diagnosing AA: Making the Case for Single-cell Profiling

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD).

Dermatitis

Dermatitis Dermatology Clinic Eczema

How to Think Like an Ichthyosis Expert

The Dermatology Digest

MARCH 14, 2024

Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis

Dermatitis Dermatology Clinic Eczema

Beyond the Basics: Antimicrobial Resistance in Acne

The Dermatology Digest

MARCH 14, 2024

Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis

Dermatitis Dermatology Clinic Eczema

Urticaria Update

The Dermatology Digest

MARCH 14, 2024

Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis

Dermatitis Dermatology Clinic Eczema

Oxymel to Fight Asthma, Inflammation, and Obesity

Aesthetics Advisor

AUGUST 22, 2023

In this era of readily available pharmaceutical products for every imaginable ailment, it can be easy to default to the drug store when we need relief. Medieval Persian pharmaceutical manuscripts refer to 1200 types of oxymel. It has not always been that way. Reposted from: [link]

Extractions

Extractions Pharmaceutical Diet Ingredients

Molluscum Contagiosum Treatment Update

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).

Treatments

Treatments Dermatitis Dermatology Eczema

“Exceptional” Long-term Data for Bimekizumab in PsO

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD).

Dermatitis

Dermatitis Dermatology Eczema Clinic

10 Best Alternatives to Antibiotics for Infection 2024

Aesthetics Advisor

MARCH 15, 2024

Here’s a review of 10 natural antimicrobials you can reach for as a first line of defense, before resorting to a pharmaceutical antibiotic. At present, cranberry supplementation can safely be suggested as complementary therapy in women with recurrent UTIs.” Some of your immune cells produce hydrogen peroxide to destroy pathogens.

Extractions

Extractions Medical Treatments Irritation

Get to Know Alys Pharmaceuticals, Inc.

The Dermatology Digest

FEBRUARY 12, 2024

Alys Pharmaceuticals, Inc. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. ” The post Get to Know Alys Pharmaceuticals, Inc. appeared first on The Dermatology Digest.

Pharmaceutical

Pharmaceutical Technology Dermatology Medical

The Role of Phototherapy in Inflammatory Skin Disease

The Dermatology Digest

AUGUST 4, 2023

1 Explanations for the decline included poor compliance, poor reimbursement, fear of skin cancer, and the promise of newer therapies, said Dr. Richard. After at least 12 weeks of concomitant combination therapy, their facial vitiligo scores improved, and their total body vitiligo scores improved. It’s a great adjunct therapy.

Eczema

Eczema Private Practice Therapy Dermatitis

Oh, The Places Dermatology Will Go in 2024!

There’s Something About Eblasakimab: Aslan, Zenyaku Partner to Investigate How it Differs From Other Biologics for AD

Off-label Pearl: Exploring the Role of Narrowband UVB Phototherapy Plus Oral JAK Inhibitors in Vitiligo

Case 2: Female, 15 Years Old

Breaking News: Japan First in the World to Approve Dupilumab for CSU

LEVEL UP Period 2 Data: AD Patients Who Switched From Dupilumab to Upadacitinib Hit Higher Treatment Targets

Sneak Peek Inside the CSU Treatment Pipeline

Think Twice: Is It Really AD?

Isotretinoin: Current Thinking and Best Practices

Rational Combinations in Acne

Late-breaking Data: Congenital Ichthyosis Treatment Update

10 Key Causes of Dry, Itchy Scalp and How to Manage Them Effectively

Exploring Emerging Treatments for CSU

Pro Pearls for Diagnosing Genodermatoses

Oh, What a Year: TDD Looks Back at 2023 in Dermatology

Oh, What a Year: TDD Looks Back at 2023 in Dermatology

Complementary Approaches to Treating Skin and Systemic Malignancy in Cancer Patients

Diagnosing AA: Making the Case for Single-cell Profiling

How to Think Like an Ichthyosis Expert

Beyond the Basics: Antimicrobial Resistance in Acne

Urticaria Update

Oxymel to Fight Asthma, Inflammation, and Obesity

Molluscum Contagiosum Treatment Update

“Exceptional” Long-term Data for Bimekizumab in PsO

10 Best Alternatives to Antibiotics for Infection 2024

Get to Know Alys Pharmaceuticals, Inc.

The Role of Phototherapy in Inflammatory Skin Disease

Stay Connected